Wyeth says FDA approves oral contraceptive Lybrel

Tue May 22, 2007 7:40pm EDT
 
[-] Text [+]

NEW YORK, May 22 (Reuters) - Drug maker Wyeth (WYE.N) said on Tuesday the U.S. Food and Drug Administration approved its low-dose oral contraceptive Lybrel, designed to eliminate a woman's monthly period.

In a statement, Wyeth said Lybrel, which will be available by prescription, is expected in U.S. pharmacies in July 2007.

 

Editor's Choice

A selection of our best photos from the past 24 hours.  Slideshow 

Most Popular on Reuters

  • Articles
  • Video
Join the Reuters Consumer Insight Panel and help us get to know you better

Join the Reuters Consumer Insight Panel and help us get to know you better